217 related articles for article (PubMed ID: 25179234)
21. Paraoxonase and arylesterase activities in patients with papillary thyroid cancer.
Korkmaz H; Tabur S; Özkaya M; Aksoy N; Yildiz H; Akarsu E
Scand J Clin Lab Invest; 2015 May; 75(3):259-64. PubMed ID: 25723374
[TBL] [Abstract][Full Text] [Related]
22. Paraoxonase and arylesterase activities in fibromyalgia.
Altindag O; Gur A; Calgan N; Soran N; Celik H; Selek S
Redox Rep; 2007; 12(3):134-8. PubMed ID: 17623520
[TBL] [Abstract][Full Text] [Related]
23. Paraoxonase and arylesterase activities in coronary artery disease.
Gur M; Aslan M; Yildiz A; Demirbag R; Yilmaz R; Selek S; Erel O; Ozdogru I
Eur J Clin Invest; 2006 Nov; 36(11):779-87. PubMed ID: 17032345
[TBL] [Abstract][Full Text] [Related]
24. Urotensin 2 and Oxidative Stress Levels in Maternal Serum in Pregnancies Complicated by Intrauterine Growth Restriction.
Celik E; Taysi S; Sucu S; Ulusal H; Sevincler E; Celik A
Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31269637
[No Abstract] [Full Text] [Related]
25. Paraoxonase and arylesterase activities in patients with cardiac syndrome X, and their relationship with oxidative stress markers.
Gur M; Yildiz A; Demirbag R; Yilmaz R; Aslan M; Ozdogru I; Erel O
Coron Artery Dis; 2007 Mar; 18(2):89-95. PubMed ID: 17301599
[TBL] [Abstract][Full Text] [Related]
26. Paraoxonase and arylesterase activity with oxidative status in children with thalassemia major.
Cakmak A; Soker M; Koc A; Erel O
J Pediatr Hematol Oncol; 2009 Aug; 31(8):583-7. PubMed ID: 19636263
[TBL] [Abstract][Full Text] [Related]
27. Total antioxidant and total oxidant states, and serum paraoxonase-1 in neonatal sepsis.
Annagür A; Örs R; Altunhan H; Kurban S; Ertuğrul S; Konak M; Uygun SS; Pekcan S; Erbay E; Mehmetoğlu İ
Pediatr Int; 2015 Aug; 57(4):608-13. PubMed ID: 25488411
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic value of thiols, paraoxonase 1, arylesterase and oxidative balance in colorectal cancer in human.
Bulbuller N; Eren E; Ellidag HY; Oner OZ; Sezer C; Aydin O; Yılmaz N
Neoplasma; 2013; 60(4):419-24. PubMed ID: 23581414
[TBL] [Abstract][Full Text] [Related]
29. Serum arylesterase and paraoxonase activities in patients with ovarian tumors.
Michalak S; Szubert S; Moszynski R; Sajdak S; Szpurek D
Taiwan J Obstet Gynecol; 2014 Dec; 53(4):490-3. PubMed ID: 25510689
[TBL] [Abstract][Full Text] [Related]
30. Plasma homocysteine, oxidative stress and endothelial function in patients with Type 1 diabetes mellitus and microalbuminuria.
Wotherspoon F; Laight DW; Browne DL; Turner C; Meeking DR; Allard SE; Munday LJ; Shaw KM; Cummings MH
Diabet Med; 2006 Dec; 23(12):1350-6. PubMed ID: 17116187
[TBL] [Abstract][Full Text] [Related]
31. Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate poor glycemic control.
Sözmen EY; Sözmen B; Delen Y; Onat T
Arch Med Res; 2001; 32(4):283-7. PubMed ID: 11440784
[TBL] [Abstract][Full Text] [Related]
32. Serum paraoxonase activity and oxidative stress in patients with adult nephrotic syndrome.
Soyoral YU; Aslan M; Emre H; Begenik H; Erdur FM; Turkel A; Selek S; Erkoc R
Atherosclerosis; 2011 Sep; 218(1):243-6. PubMed ID: 21723555
[TBL] [Abstract][Full Text] [Related]
33. Paraoxonase and arylesterase activities in untreated dipper and non-dipper hypertensive patients.
Yildiz A; Gur M; Demirbag R; Yilmaz R; Akyol S; Aslan M; Erel O
Clin Biochem; 2008 Jul; 41(10-11):779-84. PubMed ID: 18355454
[TBL] [Abstract][Full Text] [Related]
34. Assessment of the serum paraoxonase activity and oxidant/antioxidant status in patients with recurrent aphthous stomatitis.
Bilgili SG; Ozkol H; Takci Z; Ozkol HU; Karadag AS; Aslan M
Int J Dermatol; 2013 Oct; 52(10):1259-64. PubMed ID: 23834345
[TBL] [Abstract][Full Text] [Related]
35. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
[TBL] [Abstract][Full Text] [Related]
36. Decreased paraoxonase 1, arylesterase enzyme activity, and enhanced oxidative stress in patients with mitral and aortic valve insufficiency.
Yilmaz N; Simsek N; Aydin O; Yardan E; Aslan S; Eren E; Yegin A; Buyukbas S
Clin Lab; 2013; 59(5-6):597-604. PubMed ID: 23865359
[TBL] [Abstract][Full Text] [Related]
37. Paraoxonase-1 activity and oxidative stress in patients with anterior ST elevation myocardial infarction undergoing primary percutaneous coronary intervention with and without no-reflow.
Gür M; Türkoğlu C; Taşkın A; Uçar H; Börekçi A; Seker T; Gözükara MY; Kaypaklı O; Akyol S; Selek S; Sahin DY; Elbasan Z; Caylı M
Atherosclerosis; 2014 Jun; 234(2):415-20. PubMed ID: 24763406
[TBL] [Abstract][Full Text] [Related]
38. An evaluation of serum paraoxonase together with arylesterase activities and oxidative stress in children with intractable epilepsy: a cross-sectional study.
Calik M; Oguz E; Sarikaya S; Kocaturk O; Koca B; Gungor HE; Aksoy N; Yoldas TK; Iscan A
Epilepsy Res; 2014 Nov; 108(9):1591-6. PubMed ID: 25218892
[TBL] [Abstract][Full Text] [Related]
39. Attention Deficit Hyperactivity Disorder and oxidative stress: A short term follow up study.
Guney E; Cetin FH; Alisik M; Tunca H; Tas Torun Y; Iseri E; Isik Taner Y; Cayci B; Erel O
Psychiatry Res; 2015 Sep; 229(1-2):310-7. PubMed ID: 26188640
[TBL] [Abstract][Full Text] [Related]
40. Serum paraoxonase and arylesterase values as antioxidants in healthy premature infants at fasting and posprandial times.
Kahveci H; Laloglu F; Kilic O; Ciftel M; Yildirim A; Orbak Z; Ertekin V; Laloglu E
Eur Rev Med Pharmacol Sci; 2015 May; 19(10):1761-5. PubMed ID: 26044217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
